|
|
||||||||
1 From Discoveries in Sight, Devers Eye Institute, Legacy Clinical Research and Technology Center, Portland, Oregon; and the 2 Department of Psychology, University of Western Australia, Nedlands, Western Australia, Australia.
PURPOSE. In 1993, Piltz et al. observed that foveal vernier acuity thresholds for achromatic targets are elevated in patients with glaucoma. This study was undertaken to explore whether such elevated thresholds are present when subject groups are measured with targets of effectively equivalent contrast. Vernier acuity measures were also obtained with short-wavelength and frequency-doubled stimuli, to assess spatial hyperacuity performance in the short-wavelengthsensitive and magnocellular pathways, respectively.
METHODS. Twenty patients with glaucoma and 19 subjects with normal vision participated. All subjects had visual acuity of 20/25 or better. Achromatic two-dot vernier thresholds were obtained for 90% contrast dots. In addition, individual contrast thresholds to the achromatic dots were measured for each subject, and vernier thresholds were measured at 4, 8, 12, and 16 times contrast threshold. Short-wavelength vernier acuity thresholds were measured for blue dots presented on a bright yellow background. The stimulus for the frequency-doubling grating vernier acuity task was a 90% contrast, 1-cyc/deg, 25-Hz sinusoidal grating.
RESULTS. The glaucoma group demonstrated significantly higher foveal vernier acuity thresholds than control subjects for the blue-on-yellow stimulus (P = 0.002) and frequency-doubling grating stimulus (P < 0.001). No significant difference in vernier acuity between groups was found for the 90% contrast achromatic dots (P = 0.09), however a significant difference was found for the normalized contrast targets (P = 0.04).
CONCLUSIONS. Vernier acuity tasks can be used to demonstrate abnormal foveal function in glaucoma. Testing with visual-functionspecific stimuli may be effective in identifying such dysfunction. Vernier acuity, or other similar hyperacuity tasks that assess spatial sampling, may be useful in the detection of early glaucomatous damage, before it is detected with traditional perimetric tests.
This article has been cited by other articles:
![]() |
N Gupta, N Krishnadev, S J Hamstra, and Y H Yucel Depth perception deficits in glaucoma suspects Br. J. Ophthalmol., August 1, 2006; 90(8): 979 - 981. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Subramanian and C. Dickinson Spatial Localization in Visual Impairment Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 78 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. McKendrick, D. R. Badcock, and W. H. Morgan Psychophysical Measurement of Neural Adaptation Abnormalities in Magnocellular and Parvocellular Pathways in Glaucoma Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1846 - 1853. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |